戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ase (ILD) in a large cohort of patients with anti-Jo-1 antibodies.
2 0 (DNA topoisomerase I), anticentromere, and anti-Jo-1 antibodies.
3 dy revealed a modest correlation between the anti-Jo-1 antibody level and the serum creatine kinase (
4 eries have examined the relationship between anti-Jo-1 antibody levels and myositis disease activity,
5 s were used to identify associations between anti-Jo-1 antibody levels and organ-specific disease act
6 ematically reexamine the association between anti-Jo-1 antibody levels and various disease manifestat
7 ients with idiopathic inflammatory myopathy, anti-Jo-1 antibody levels correlated modestly with muscl
8 analyses of 11 patients with serial samples, anti-Jo-1 antibody levels correlated significantly with
9 er longitudinal subset of patients that link anti-Jo-1 antibody levels to muscle, joint, lung, and gl
10                                        Serum anti-Jo-1 antibody levels were quantified using 2 indepe
11 atistically significant associations between anti-Jo-1 antibody-positive ILD and elevated serum level
12 trated disease-specific associations between anti-Jo-1 antibody-positive ILD and serum levels of CRP
13 to assess the serum proteins associated with anti-Jo-1 antibody-positive ILD.
14 g studies determined the existence of ILD in anti-Jo-1 antibody-positive individuals whose data were
15                                 Among the 90 anti-Jo-1 antibody-positive individuals with sufficient
16                      In this large cohort of anti-Jo-1 antibody-positive individuals, the incidence o
17 oss-sectional assessment of 81 patients with anti-Jo-1 antibody revealed a modest correlation between

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。